According to a new market report published by Persistence Market Research “Global Market Study on Home Infusion Therapy Devices – Needleless Connectors to Witness Highest Growth by 2020”, the global home infusion therapy devices market was valued at US$ 15,905.1 Mn in 2014 and is expected to grow at a CAGR of 9% from 2014 to 2020, to reach US$ 26,747.8 Mn by 2020.
Home infusion therapy facilitates intravenous at-home administration of medicines into the patient’s body through needle and catheter. The therapy is prescribed by physicians and administered by trained healthcare professionals. It is used when oral medication is not effective for the treatment of diseases such as cancer and gastrointestinal diseases. It is also used in the treatment of diabetes, cystic fibrosis, dehydration, and acute infections. Home infusion therapy reduces time spent by patients in hospitals, nursing homes, and clinics. The therapy is used to administer drugs, antibiotics, nutrients, and other fluids into the veins on a daily, weekly, or monthly basis, depending on the patient’s condition.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/2893
Some of the major players in the home infusion therapy devices market:
- Hospira, Inc.
- B. Braun Melsungen AG.
- Caesarea Medical Electronics.
- Fresenius Kabi AG.
- Smiths Medical.
- CareFusion Corporation.
- ICU Medical, Inc.
- JMS Co. Ltd.
- Terumo Corporation.
Home infusion therapy is an effective and safe alternative against conventional hospitalization for the treatment of diseases. This is due to convenience and friendly environment at the patient’s home, which helps in faster recovery from diseases. Home infusion therapy includes total parenteral nutrition, infusion antibiotic therapy, hydration therapy, IV steroid therapy, chemotherapy, enteral therapy, and pain management. Some major infusion devices used for administration of medicines are infusion pump, intravenous equipment, and needleless connectors. Infusion pumps are categorized as ambulatory infusion pump, large volume infusion pump, and syringe infusion pump.
Globally, the home infusion therapy devices market is witnessing significant growth due to the expanding home care market for infusion therapy and increasing application of infusion devices for relieving pain. Moreover, rising aging population, increasing number of chronic diseases, and technological advancements in infusion devices are also supporting the growth of home infusion therapy devices market. However, increasing risk to patient safety and occurrence of mistakes while using infusion devices as well as issues related to reimbursement policies for home infusion therapy inhibit the growth of the market.
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/2893
In North America, the home infusion therapy devices market is growing due to increasing number of patients with chronic diseases such as cancer, AIDS, and diabetes. In addition, growing aging population is also supporting the growth of home infusion therapy devices market in the region.
The home infusion therapy devices market in Europe is growing due to increasing aging population and rising popularity of non-hospital procedures in the region. Furthermore, increasing number of chronic diseases which requires home infusion therapy, such as cancer, diabetes, and AIDS, is also boosting growth of the Europe home infusion therapy devices market. According to the National Center for Biotechnology Information (NCBI) – a branch of the National Institutes of Health – around 3.4 million new cases of cancer and 1.7 million deaths from cancer were reported in Europe in 2012. Moreover, according to the Oxford Journals, approximately 7 37,747 men and 5 76,489 women died from cancer in Europe in 2013. Furthermore, according to the European Diabetes Leadership Forum 2012, Copenhagen, about 35 million adults in Europe were suffering from diabetes in 2011, which is anticipated to rise to 43 million by 2030.
Asia represents the fastest-growing market for home infusion therapy devices. This is primarily due to growing aging population and cost effectiveness of home infusion therapy. In addition, rising popularity of non-hospital procedures and increasing prevalence of chronic diseases in the region is further driving the market. According to the National Home Infusion Association, home infusion therapy is more cost-efficient compared to hospitalization treatment. For instance, home infusion therapy cost nearly US$ 200 a day compared to less than US$ 2,000 a day in a hospital. According to the Wisut Jaijagcome/East-West Center, the number of people aged 65 years and above in Asia was 207 million in 2000 and the number is expected to reach 857 million by 2050.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/2893
The global home infusion therapy devices market is segmented as follows:
By Type of Device
- Infusion pump
- Intravenous set
- Needleless connector
By Infusion Pump
- Volumetric infusion pump
- Syringe infusion pump
- Insulin infusion pump
- Enteral infusion pump
- Ambulatory infusion pump
- Patient-controlled analgesia (PCA) infusion pump
- Implantable infusion pump
- Enteral nutrition
- Specialty pharmaceuticals
- Total parenteral nutrition (TPN)
- Pain management
- Hydration infusion pump
By Type of Disease
- North America
About Us: Persistence Market Research
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Japan Office: 1-2-1 Kinshi Arca Central Building
14/F Tokyo, 130-0013, Japan
Sales – firstname.lastname@example.org
Website – https://www.persistencemarketresearch.com
Why pay for news and opinions when you can get them for free?
Subscribe for free now!
NEWS3 days ago
Novo Nordisk contracts South Africa’s Aspen to produce insulin for African nations
NEWS3 days ago
B&Q owner Kingfisher cuts profit forecast as Poland, France drag
NEWS2 days ago
King Charles heads to France for three-day state visit
TECHNOLOGY1 day ago
Digital fraud and scams: The victims, the scammers, and the hidden human cost